Separately, Craig Hallum reiterated a hold rating on shares of Sientra in a report on Tuesday, October 31st.
Sientra Stock Performance
Hedge Funds Weigh In On Sientra
Hedge funds and other institutional investors have recently bought and sold shares of the company. Mirabella Financial Services LLP acquired a new position in Sientra in the first quarter valued at $26,000. Advisor Group Holdings Inc. lifted its holdings in Sientra by 230.9% in the first quarter. Advisor Group Holdings Inc. now owns 11,930 shares of the medical instruments supplier’s stock valued at $26,000 after buying an additional 8,325 shares during the period. LPL Financial LLC acquired a new position in Sientra in the second quarter valued at $31,000. Wolverine Trading LLC acquired a new position in Sientra in the second quarter valued at $32,000. Finally, Virtu Financial LLC acquired a new position in Sientra in the second quarter valued at $32,000. Institutional investors and hedge funds own 15.38% of the company’s stock.
Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.
- Five stocks we like better than Sientra
- How to Find Cloud Software Company Stocks to Trade and Invest
- S&P 500’s Whirlwind: Big gains, warning whispers & tactical moves
- Investing in Commodities: What Are They? How to Invest in Them
- MarketBeat Week in Review – 11/13 – 11/17
- Health Care Stocks Explained: Why You Might Want to Invest
- 3 large caps with red hot RSIs with upside
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.